Stock Events

Stock Events

Carvolix. 

€2.81
0
-€0.04-1.4% Today

Statistics

Day High
2.9
Day Low
2.81
52W High
5.22
52W Low
1.83
Volume
5,214
Avg. Volume
-
Mkt Cap
110.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-357.92%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8.24MRevenue
-29.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CVX.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap92.25B
Boston Scientific Corporation is a leading developer, manufacturer, and marketer of medical devices that are used in a broad range of interventional medical specialties, competing directly with Affluent Medical's product offerings in the cardiovascular and endovascular markets.
Medtronic
MDT
Mkt Cap106.97B
Medtronic plc is a global leader in medical technology, services, and solutions, with a wide range of products that compete in the areas of cardiac and vascular therapies, where Affluent Medical also operates.
Edwards Lifesciences
EW
Mkt Cap48.52B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, directly competing with Affluent Medical's focus on innovative cardiovascular devices.
Abbott Laboratories
ABT
Mkt Cap158.36B
Abbott Laboratories operates in various segments, including cardiovascular devices, competing with Affluent Medical in the development and marketing of medical devices for heart diseases and other vascular conditions.
Stryker
SYK
Mkt Cap125.43B
Stryker Corporation is a medical technology company that offers products in various medical specialties, including orthopedics and cardiology, competing with Affluent Medical in the medical device market.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but has expanded into other areas, including surgical products that could compete with Affluent Medical's offerings.
Baxter International
BAX
Mkt Cap9.38B
Baxter International Inc. provides a broad portfolio of essential healthcare products, including advanced surgeries, pharmaceuticals, and medical devices that can compete with Affluent Medical's offerings in certain healthcare procedures.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson operates in the healthcare field with a broad range of products, including medical devices through its subsidiary Ethicon and others, competing with Affluent Medical in various healthcare and medical device markets.

About

Carvolix SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was formerly known as Affluent Medical SA and changed its name to Carvolix SA in February 2026. Carvolix SA was founded in 2011 and is headquartered in Aix-en-Provence, France.
Show more...
CEO
ISIN
FR0013333077

Listings

STU
DE
0JZ.STU
MU
DE
0JZ.MU
F
DE
0JZ.F
PA
FR
CVX.PA

0 Comments

Share your thoughts

FAQ

What is Carvolix. stock price today?▼
The current price of CVX.PA is €2.81 EUR — it has decreased by -1.4% in the past 24 hours. Watch Carvolix. stock price performance more closely on the chart.
What is Carvolix. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Carvolix. stocks are traded under the ticker CVX.PA.
What is Carvolix. market cap?▼
Today Carvolix. has the market capitalization of 110.57M
What is Carvolix. revenue for the last year?▼
Carvolix. revenue for the last year amounts to 8.24M EUR.
What is Carvolix. net income for the last year?▼
CVX.PA net income for the last year is -29.48M EUR.
In which sector is Carvolix. located?▼
Carvolix. operates in the Other sector.
When did Carvolix. complete a stock split?▼
Carvolix. has not had any recent stock splits.